In Stem Cells, 21 settembre 2006, di Xin Zhang, Petra Stojkovic, Stefan Przyborski, Michael Cooke, Lyle Armstrong, Majlinda Lako, Miodrag Stojkovic.
Abstract
Human embryonic stem cells (hESC) hold huge promise in modern regenerative medicine, drug discovery, and as a model for studying early human development. However, usage of embryos and derivation of hESC for research and potential medical application has resulted in polarised ethical debates since the process involves destruction of viable developing human embryos. Here we describe that not only developing embryos (morulae and blastocysts) of both good and poor quality but also arrested embryos could be used for the derivation of hESC. Analysis of arrested embryos demonstrated that these embryos express pluripotency marker genes such OCT4, NANOG and REX1. Derived hESC lines also expressed specific pluripotency markers (TRA-1-60, TRA-1-81, SSEA4, alkaline phosphatase, OCT4, NANOG, TERT and REX1) and differentiated under in vitro and in vivo conditions into derivates of all three germ layers. All the new lines including line derived from late arrested embryo have normal karyotype. These results demonstrate that arrested embryos are additional valuable resources to surplus and donated developing embryos and should be used to study early human development or derive pluripotent hESC.
Per l’intero articolo.
sabato 23 settembre 2006
Derivation of human embryonic stem cells from developing and arrested embryos
Iscriviti a:
Commenti sul post (Atom)
Nessun commento:
Posta un commento